Category: us corporate news

us corporate news

Victory Capital Counters Trian With Superior $57.05 Per Share Proposal to Acquire Janus Henderson, Highlights Track Record and Shareholder Value Creation 1

Minichart

March 23, 2026

Victory Capital Sets the Record Straight on Janus Henderson ...

Continue Reading 0

us corporate news

Glass Lewis Recommends Aptose Shareholders Vote FOR Hanmi Pharmaceutical Arrangement in 2026 Proxy Advisory Update

Minichart

March 23, 2026

Glass Lewis Endorses Aptose Biosciences’ Plan of Arrangement...

Continue Reading 0

us corporate news

Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1 Billion to Expand Retina Consultants of America

Minichart

March 23, 2026

Cencora to Acquire EyeSouth Partners' Retina Business: Key D...

Continue Reading 0

us corporate news

Solo Brands, Inc. (NYSE: SBDS) Issues Fiscal Year 2026 Financial Guidance and Outlook 6

Minichart

March 23, 2026

Solo Brands Issues 2026 Financial Guidance - Key Investor Up...

Continue Reading 0

us corporate news

Thermon Group Holdings, Inc. Files Form 8-K with SEC – Company Details, Address, and NYSE Listing Information

Minichart

March 23, 2026

Thermon Group Holdings, Inc. — SEC Form 8-K Filing Analysis ...

Continue Reading 0

us corporate news

Arbutus Biopharma Corporation (ABUS) Form 8-K Filing Details, Key Financials, and Company Information

Minichart

March 23, 2026

Arbutus Biopharma Reports Q4 and Full-Year 2025 Financial Re...

Continue Reading 0

us corporate news

InMed Pharmaceuticals Reports Positive INM-901 Data in Human Brain Organoid Models for Alzheimer’s Disease Program 12

Minichart

March 23, 2026

InMed Pharmaceuticals Reports Positive Preclinical Data for ...

Continue Reading 0

us corporate news

Cabaletta Bio Reports 2025 Financial Results, Highlights Progress on Rese-cel CAR-T Cell Therapy and Upcoming Clinical Milestones

Minichart

March 23, 2026

Cabaletta Bio 2025 Full Year and Q4 Earnings & Business Upda...

Continue Reading 0

us corporate news

State Street Corp 8-K Filing March 2026 – Company Information, Securities, and XBRL Data Summary

Minichart

March 23, 2026

Summary of Filing State Street Corporation (NYSE: STT), a...

Continue Reading 0

us corporate news

Xilio Therapeutics Extends Cash Runway Through 2027 and Advances Masked Immuno-Oncology Pipeline, Including XTX501 and Multi-Specific T Cell Engagers 123

Minichart

March 23, 2026

Xilio Therapeutics Announces Significant Pipeline Progress, ...

Continue Reading 0